Given the observed inhibition of NSCLC cell migration after blocking Ephrin B3 expression we next analyzed if Ephrin B3 directly binds to EphA2 and other Ephs in these cells (Figure 3). The gene discussed is EPHA2; the disease is non-small cell lung carcinoma.